Search Results - "Hatton, M Q"

The Use of Palliative Radiotherapy in the Treatment of Lung Cancer by King, J., Patel, K., Woolf, D., Hatton, M.Q.

“…There have been significant advances in the systemic treatment of stage IV lung cancer, which is now recommended first line in patients with adequate fitness…”
Get full text

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic by Faivre-Finn, C., Fenwick, J.D., Franks, K.N., Harrow, S., Hatton, M.Q.F., Hiley, C., McAleese, J.J., McDonald, F., O'Hare, J., Peedell, C., Pope, T., Powell, C., Rulach, R., Toy, E.

“…Patients treated with curative-intent lung radiotherapy are in the group at highest risk of severe complications and death from COVID-19. There is therefore an…”
Get full text

Lung Cancer in 2022 and Beyond by Thippu Jayaprakash, K., Hanna, G.G., Hatton, M.Q.

Get full text

Functional Image-guided Radiotherapy Planning for Normal Lung Avoidance by Ireland, R.H., Tahir, B.A., Wild, J.M., Lee, C.E., Hatton, M.Q.

“…For patients with lung cancer undergoing curative intent radiotherapy, functional lung imaging can be incorporated into treatment planning to modify the dose…”
Get full text

Longstanding Challenges in Lung Cancer: Are We Meeting Them? by Snee, M, Hatton, M.Q

Get full text

Stereotactic ablative radiotherapy in the UK: current status and developments by Jain, P, Baker, A, Distefano, G, Scott, A J D, Webster, G J, Hatton, M Q

“…Stereotactic ablative radiotherapy (SABR) has developed from the principles and techniques used in the stereotactic radiosurgery treatment of brain metastases…”
Get full text

Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres by Sanganalmath, P., Lester, J.E., Bradshaw, A.G., Das, T., Esler, C., Roy, A.E.F., Toy, E., Lester, J.F., Button, M., Wilson, P., Comins, C., Atherton, P., Pickles, R., Foweraker, K., Walker, G.A., Keni, M., Hatton, M.Q.

“…Continuous hyperfractionated accelerated radiotherapy (CHART) remains an option to treat non-small cell lung cancer (NSCLC; NICE, 2011). We have previously…”
Get full text

The Use of Lung Dose–Volume Histograms in Predicting Post-radiation Pneumonitis After Non-conventionally Fractionated Radiotherapy for Thoracic Carcinoma by Clenton, S.J., Fisher, P.M., Conway, J., Kirkbride, P., Hatton, M.Q.

“…To assess the use of lung dose–volume histogram (DVH) parameters (specifically V 20Gy) in the prediction of radiation pneumonitis for non-conventional fraction…”
Get full text

Current Controversies in Breast Cancer – Do We Have the Answers? by Coles, C.E, Hatton, M.Q

Get full text

Chemotherapy, Erythropoietin and Bloodless Surgery in a Jehovah's Witness by Brown, J.E., Hatton, M.Q., Melchers, R., Goldstraw, P., Coleman, R.E.

Get full text

Quality of life, support and smoking in advanced lung cancer patients: a qualitative study by Rowland, C, Danson, S J, Rowe, R, Merrick, H, Woll, P J, Hatton, M Q, Wadsley, J, Ellis, S, Crabtree, C, Horsman, J M, Eiser, C

“…Lung cancer is the most common cancer and smoking is the principal cause. Due to poor survival rates, symptom palliation and promotion of health-related…”
Get more information

Escalation and Intensification of Radiotherapy for Stage III Non-small Cell Lung Cancer: Opportunities for Treatment Improvement by Fenwick, J.D, Nahum, A.E, Malik, Z.I, Eswar, C.V, Hatton, M.Q, Laurence, V.M, Lester, J.F, Landau, D.B

“…Abstract In this overview we review and model how radiotherapy tumour control and complication rates vary with dose, fractionation, schedule duration,…”
Get full text

Continuous Hyperfractionated Accelerated Radiotherapy (CHART) and Non-conventionally Fractionated Radiotherapy in the Treatment of Non-small Cell Lung Cancer: a Review and Consideration of Future Directions by Hatton, M.Q.F, Martin, J.E

“…Abstract There is a well-established role for radiation treatment in the management of non-small cell lung cancer. As a single modality, it is indicated as a…”
Get full text

The Management and Survival of Patients with Advanced Germ-Cell Tumours: Improving Outcome in Intermediate and Poor Prognosis Patients by Bhala, N., Coleman, J.M., Radstone, C.R., Horsman, J.M., George, J., Hancock, B.W., Hatton, M.Q., Coleman, R.E.

“…Aims: The survival of germ-cell tumours (GCT) was transformed after the introduction of cisplatin-based therapy. Previous trials have indicated BEP (bleomycin,…”
Get full text

Does sedation help in fibreoptic bronchoscopy? by Hatton, M Q F, Allen, M B, Vathenen, A S, Mellor, E, Cooke, N J

“…Drug Placebo Difference (95% confidence interval P value * Phenoperidine and droperidol Mean age of patients (years) 64.1 64.1 - - No of men:women 31:19 36:15…”
Get full text

Accelerated Radical Radiotherapy for Non-small Cell Lung Cancer using Two Common Regimens: a Single-centre Retrospective Study of Outcome by Pemberton, L.S, Din, O.S, Fisher, P.M, Hatton, M.Q

“…Abstract Aims A variety of radical radiotherapy regimens are in use for non-small cell lung cancer. Continuous hyperfractionated accelerated radiotherapy…”
Get full text

Review of Testing and Use of Adjuvant Trastuzumab across a Cancer Network — Are We Treating the Right Patients? by Coulson, S.G, Kumar, V.S, Manifold, I.M, Hatton, M.Q, Ramakrishnan, S, Dunn, K.S, Purohit, O.P, Bridgewater, C, Coleman, R.E

“…Abstract This review of practice assessed all early breast cancer patients diagnosed over 12 months to determine the frequency of human epidermal growth factor…”
Get full text

Compliance with oral corticosteroids during steroid trials in chronic airways obstruction by Hatton, M Q, Allen, M B, Vathenen, S V, Feely, M P, Cooke, N J

“…BACKGROUND: Corticosteroid trials are an important part of the assessment of patients with chronic airways obstruction, but false negative results will occur…”
Get full text

Pancoast syndrome: an unusual presentation of adenoid cystic carcinoma by Hatton, M Q, Allen, M B, Cooke, N J

“…We report on a patient with primary pulmonary adenoid cystic carcinoma presenting with Pancoast syndrome. Pancoast syndrome has not previously been described…”
Get more information

Response on Behalf of the UK Stereotactic Body Radiotherapy Consortium to Brock et al. Clin Oncol (R Coll Radiol) 2008;20(9):666–676 by Franks, K.N, Jain, P, Dahele, M, Peedell, C, Hatton, M.Q, Faivre-Finn, C

Get full text